FDA approves drug for inflammatory disease

Mar 06, 2008

The U.S. Food and Drug Administration approved the drug rilonacept to treat a group of rare diseases causing rash, fever, chills and joint pain.

Rilonacept, marketed under the name Arcalyst by Regeneron Pharmaceuticals, received marketing approval for the treatment of Cyropyrin-Associated Periodic Syndromes, including Familial Cold Auto-inflammatory Syndrome and Muckle-Wells Syndrome in adults and children ages 12 and older.

The familial cold syndrome is an "orphan" hereditary disease affecting only about 300 people in the United States, 90 percent of whom can trace their ancestry to a single person who came to America in the 1600s, the University of California's San Diego School of Medicine said Wednesday in a news release. Symptoms can be triggered at any time by exposure to cold temperatures, stress or exercise,

The drug is based on a discovery by Dr. Hal Hoffman, a professor at the medical school, who identified the genetic basis of the disease as a mutation that causes alterations in the protein cryopyrin.

Copyright 2008 by United Press International

Explore further: Drug for rare blood disorder developed at Penn receives orphan drug status from EU

add to favorites email to friend print save as pdf

Related Stories

Bat-killing white-nose syndrome continues to spread

Apr 15, 2013

It was a typically cold winter day when Greg Turner, a wildlife biologist with the Pennsylvania Game Commission, unlocked the gate at the historic Durham Mine in upper Bucks County, Pa., and stepped into the darkness.

Email stress test: Experiment unplugs workers for 5 days

Sep 07, 2012

Slave to your email? Wonder what would happen if you had to do without it? University of California-Irvine informatics professor Gloria Mark was curious - so she recently led a study that separated 13 people from their email ...

Biologists head to bunkers to fight bat disease

Dec 26, 2010

(AP) -- Biologist Susi von Oettingen walked into the dark World War II-era military bunker and took out her flashlight. Among the old pipes, wires and machinery parts, she saw some bats hanging from cracks ...

Rare Stevens-Johnson syndrome can be unpredictable, deadly

Apr 07, 2010

For Cody Strickland, it began with poison ivy. In his 21 years, the outdoorsy electrician was no stranger to the rash, which caught him for the last time in early February, at a bonfire party on the shores of Lake Pat Cleburne. ...

Recommended for you

Expression of privilege in vaccine refusal

3 hours ago

Not all students returning to school this month will be up to date on their vaccinations. A new study conducted by Jennifer Reich, a researcher at the University of Colorado Denver, shows that the reasons why children may ...

Using computers to design drugs

Aug 22, 2014

Designing a new medicine is an expensive and time consuming business. Typically it takes around $2 billion and ten years for a new drug to move from its initial design in the lab, to the clinic. All the ...

Lilly psoriasis drug fares well in late-stage test

Aug 22, 2014

Drugmaker Eli Lilly and Co. said its potential psoriasis treatment fared better than both a fake drug and a competitor's product during late-stage testing on patients with the most common form of the skin disease.

User comments : 0